Found 170 matching trials
Evaluation of Changes in Pancreatic Fat Content Using Advanced MR Sequences in Diabetics on Dapagliflozin Therapy PHASE4 The study aimed to assess changes in pancreatic fat content in people with ...
Show More Location
Deptt of Endocrinology
Learn More & Join Trial
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency PHASE3 Background. Treatment with intravenous iron has been shown to improve sympt...
Show More Location
Hospital de Clínicas de Porto Alegre
Learn More & Join Trial
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients PHASE4 Long-term allograft function in kidney transplant recipients (KTRs) remain ...
Show More Location
University of Colorado Anschutz Medical Campus
Learn More & Join Trial
Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia PHASE2 There are approximately 400,000 people in the UK who are living with type 1...
Show More Location
Clinical Research Unit, OCDEM, Churchill Hospital
Learn More & Join Trial
A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients PHASE4 This is a randomised, placebo-controlled, double-blind, parallel-group, int...
Show More Learn More & Join Trial
Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF) PHASE4 The goal of this clinical trial is to evaluate the short-term clinical outc...
Show More Location
Aswan Heart Centre
Learn More & Join Trial
Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale PHASE2 This study aims at exploring the use of Dapagliflozin and Empagliflozin in ...
Show More Location
Centre Hospitalier Universitaire Vaudois (CHUV)
Learn More & Join Trial
Dapagliflozin in Type 1 Diabetes PHASE4 Dapagliflozin is a highly selective, reversible and potent inhibitor of the...
Show More Location
Medical University Innsbruck, Department of Internal Medicine I
Learn More & Join Trial
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care PHASE3 Background Acute Kidney Injury (AKI) is a potentially life-threatening cond...
Show More Learn More & Join Trial
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients PHASE3 This is a 28-week, multi-center, randomized, double-blind, placebo-controll...
Show More Location
Diabeteszentrum Oldenburg
Learn More & Join Trial